98%
921
2 minutes
20
Aim: To describe the development of social function in children with cerebral palsy (CP) classified in all levels of the Communication Function Classification System (CFCS).
Method: This prospective, longitudinal population-based cohort study recruited children with CP born in Queensland, Australia. Social functioning was measured using the Pediatric Evaluation of Disability Inventory (PEDI) social function domain at 2 years, 2 years 6 months, 3 years, 4 years, and 5 years, and the PEDI Computer Adaptive Test (PEDI-CAT) social/cognitive domain at 8 to 12 years.
Results: Seventy-four children provided 356 observations. PEDI-CAT social/cognitive scaled scores at 8 to 12 years were (mean [SD] n) CFCS level I, 68.6 (2.7) 45; CFCS level II, 64.0 (3.4) 10; CFCS level III, 63.5 (3.7) 4; CFCS level IV, 56.8 (5.0) 9; CFCS level V, 47.2 (5.8) 6. Scores within expected range for age (not less than 2 SD below mean) at 8 to 12 years were achieved by 35 (78%) children in CFCS level I and four (14%) in CFCS levels II to V. Forty-nine per cent of children scored at least two standard deviations below the population mean on a proxy measure of fluid intelligence. Intellectual impairment was associated with lower PEDI-CAT social/cognitive scaled scores in univariable analysis (β = -8.3, 95% confidence interval - 10.91 to -5.63; p < 0.001) but had a smaller effect when modelled together with CFCS.
Interpretation: Social function attained by 8 to 12 years of age was strongly related to level of communication function (CFCS). The small number of children classified in CFCS levels II to V necessitates caution when viewing these individual CFCS level trajectories.
What This Paper Adds: There is a strong relation between social functioning and Communication Function Classification System (CFCS) levels. At 8 to 12 years, 35 out of 45 children in CFCS level I met social functioning age expectations. Twenty-five out of 29 in CFCS levels II to V had social functioning below that expected for age. CFCS and age were more strongly associated with development of social functioning than Gross Motor Function Classification System or Manual Ability Classification System and age.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953437 | PMC |
http://dx.doi.org/10.1111/dmcn.15439 | DOI Listing |
J Chem Phys
August 2025
College of Science, China University of Petroleum (East China), Qingdao 266580, Shandong, China.
Hydrofluoroolefins (HFOs) have emerged as promising alternatives for ozone-depleting chlorofluorocarbons (CFCs) and hydrochlorofluorocarbons (HCFCs) due to their drastically shorter atmospheric lifetimes (days to weeks vs years to decades for CFCs and HCFCs) and significantly lower global warming potential. While HFOs' rapid degradation minimizes their direct environmental accumulation, the ecological risks posed by their reactive degradation intermediates-particularly hydrofluorocarbonyl oxide (HFCOO), a fluorinated Criegee intermediate generated via HFO-ozone reactions-require urgent mechanistic clarification. The atmospheric persistence and chemical reactivity of HFCOO are intrinsically governed by its excited-state dynamics, where competing photochemical pathways determine whether it undergoes ultrafast dissociation or survives to mediate secondary pollutant formation.
View Article and Find Full Text PDFBiomed Pharmacother
September 2025
Department of Gastroenterology and Advanced Medical Sciences, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido 078-8510, Japan; Division of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido
Recent advances in therapy have significantly improved long-term survival in pediatric B-cell acute lymphoblastic leukemia (B-ALL). However, relapse still occurs in 15-20 % of cases, and post-relapse survival rates remain suboptimal at 30-60 %. Therefore, novel therapeutic strategies effective against both primary and relapsed B-ALL are needed.
View Article and Find Full Text PDFFront Immunol
July 2025
Pediatria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Introduction: Cardiofaciocutaneous syndrome (CFCS) is a rare syndromic disorder caused by germline mutations affecting the RAS/MAPK pathway. It is characterized by distinctive craniofacial dysmorphism, congenital heart defects, skin abnormalities, gastrointestinal dysfunction, neurocognitive impairment, and epilepsy. Emerging evidence suggests an association with hypogammaglobulinemia, but a comprehensive characterization of immunological abnormalities in CFCS is lacking.
View Article and Find Full Text PDFIntroduction: The care paths and lives of cystic fibrosis patients were profoundly altered during the health crisis in France. Patient experiences can be used to provide lessons on how to adapt to a crisis.
Purpose Of The Study: The ExPaParM collaborative study analyzed the experiences of a varied sample of patients and identified changes in practices in Cystic Fibrosis Centers (CFC), with the aim of characterizing adaptations made and destabilizing events experienced during this crisis, using a systemic approach.
J Intellect Disabil Res
August 2025
Department of Pediatrics, University of Minnesota Medical School, Minneapolis, USA.
Background: Challenging behaviours such as self-injury and aggression are prevalent among individuals with intellectual disability (ID), significantly impacting quality of life. Cardiofaciocutaneous syndrome (CFCS), a rare multisystem genetic disorder caused by variants in the BRAF, MAP2K1, MAP2K2, or KRAS genes, commonly presents with ID and other neurobehavioural features. To inform effective clinical management, we aimed to characterise and quantify challenging and repetitive behaviours in CFCS, identify functions that may maintain the behaviours, and examine associations with genotype and neurological comorbidities.
View Article and Find Full Text PDF